Deadline: 12-Feb-21
Positive Action is inviting applications for the 2021 Innovator Grants (Round 1) focusing on Community Based Harm Reduction Services.
The application should be specific in describing how the interventions that applicants want to implement is going to support people and communities of people who inject drugs to reimagine and innovate service delivery models that enable person-centered, stigma free and community-based harm reduction and HIV care.
The call is open to eight countries where there is a significant rise in HIV incidence among people who inject drugs, established needle and syringe programmes and opioid substitution therapy services, as well as strong potential for adoption of innovative community-led service delivery.
Topic Areas
This Innovator Round focuses on the following topic areas:
- Collaboration between PWID, broader community, healthcare providers and/or government stakeholders to drive referral, uptake and retention to community-based HIV and harm reduction services.
- Innovative community-based HIV and harm reduction service delivery in rapidly changing environments or contexts, including, but not limited to, peer-led models.
Funding Information
- Innovator grants: Positive Action will award up to £50,000 per year over two years (up to £100,000 over two years).
Eligibility Criteria
- Who can apply?
- Non-governmental and community-based organisations that are or can deliver innovative and sustained harm reduction services at the community level. The Innovator funding round is about trying out new ideas, changing existing models or developing new ones in ensuring that people who use drugs are able to access the services they require, in their community.
- Focus countries: Indonesia, Kenya, Myanmar, Mauritius, Nepal, South Africa, Tanzania, and Vietnam.
- Financial eligibility requirements
- The program does not provide grants of more than 50% of an organisation’s total annual revenue (income) in low- and middle-income countries and 25% of an organisation’s total annual revenue (income) in high income countries (or 10% over a 12-month period for US-based organisations).
- Applicant will be required to provide a list of any existing secured funding organisation has received or will receive from ViiV Healthcare for any project/work in this last 12months. Please do not include this current application in this list.
For more information, visit https://viivhealthcare.com/en-gb/supporting-the-community/new-positive-action-strategy-and-funding/#tab-01481534504-4
